DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Oxiracetam
Oxiracetam
Treatment Protocol Copyright © 2018 Kostoff Et Al
(19) United States (12) Patent Application Publication (10) Pub
Cognitive Functions Enhancers Racetams
NPS) Via Online Drugsmarkten
Neuroenhancement in Healthy Adults, Part I: Pharmaceutical
WO 2016/001643 Al 7 January 2016 (07.01.2016) P O P C T
Effects of the Histamine H3 Receptor Antagonist ABT-239 on Cognition
The Use and Impact of Cognitive Enhancers Among University Students: a Systematic Review
Assessing and Evaluating Biomarkers and Chemical Markers by Targeted and Untargeted Mass Spectrometry-Based Metabolomics
Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0192440 A1
World of Cognitive Enhancers
Implications for the Dynamics of Long-Term Memory
Morphine Tolerance and Reward but Not Expression Of
30Th Annual Meeting of Society for Neuroscience. New Drugs Affecting the Central Nervous System New Orleans, Louisiana, USA November 4–9, 2000
Bibliography Section
Stembook 2018.Pdf
Psychoactive Medications Grouped by Drug Class and Foods Studied Tor Psychoactive Effects
Evaluation of Novel Dual-Hit Models of 'Schizophrenia-Like'
Top View
Alternations of NMDA and GABAB Receptor Function in Development: a Potential Animal Model of Schizophrenia
Cocaine, Nicotine, and Their Conditioned Contexts Enhance Consolidation of Object Memory in Rats
Practice Parameter: Management of Dementia (An Evidence-Based Review)
Nootropics Use in the Workplace: Psychiatric and Ethical Aftermath Towards the New Frontier of Bioengineering
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Drugs Affecting the Central Nervous System
(12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al
Pharmacology and Toxicology
Nootropics for Better Judgment
Psicotrópicos Y Estupefacientes Visión Farmacológica Y Normativa
(12) Patent Application Publication (10) Pub. No.: US 2014/0349976 A1 HACKSELL Et Al
(12) United States Patent (10) Patent No.: US 9,358,295 B2 Tygesen Et Al
2-Pyrrolidinone Moiety Is Not Critical for the Cognition-Enhancing Activity of Piracetam-Like Drugs
Substance Abuse in the Workplaces of Our Bodies and Mind
Facilitating Effect of Oxiracetam and Piracetam on Acquisition of Discrete Two-Way Shuttle Avoidance in Normal Mice
Trend Analysis of a Database of Intravenous Pharmacokinetic Parameters in Humans for 1352 Drug Compounds
Racetam Cheatsheet
Harmonized Tariff Schedule of the United States (2006) (Rev
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Protective Effects of Histamine H3-Receptor Ligands In
(12) Patent Application Publication (10) Pub. No.: US 2017/0056347 A1 Glick Et Al
(12) United States Patent (10) Patent No.: US 8,480,637 B2 Ferrari Et Al
Brain Science, Addiction and Drugs
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Harmonized Tariff Schedule of the United States (2003) -- Supplement 1 Annotated for Statistical Reporting Purposes
1111111111111111111Imnumu
Study Protocol
(19) United States (12) Patent Application Publication (10) Pub
Resolution Ap (2000) 1
Pharmaceuticals & Intermediates
The Novel Nootropic Compound DM232 (UNIFIRAM)